.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Harvard Business School
McKesson
Chubb
Teva
Farmers Insurance
Cantor Fitzgerald
Accenture
Johnson and Johnson
Mallinckrodt

Generated: November 19, 2017

DrugPatentWatch Database Preview

Gentamicin sulfate; prednisolone acetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for gentamicin sulfate; prednisolone acetate and what is the scope of gentamicin sulfate; prednisolone acetate freedom to operate?

Gentamicin sulfate; prednisolone acetate
is the generic ingredient in one branded drug marketed by Allergan and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for gentamicin sulfate; prednisolone acetate. One supplier is listed for this compound.

Summary for gentamicin sulfate; prednisolone acetate

Pharmacology for gentamicin sulfate; prednisolone acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan
PRED-G
gentamicin sulfate; prednisolone acetate
SUSPENSION/DROPS;OPHTHALMIC050586-001Jun 10, 1988RXYesYes► Subscribe► Subscribe► Subscribe
Allergan
PRED-G
gentamicin sulfate; prednisolone acetate
OINTMENT;OPHTHALMIC050612-001Dec 1, 1989RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Merck
Cerilliant
Argus Health
Cipla
Moodys
McKinsey
Deloitte
Teva
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot